These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

876 related articles for article (PubMed ID: 28248701)

  • 1. Autoimmune encephalitis with anti-leucine-rich glioma-inactivated 1 or anti-contactin-associated protein-like 2 antibodies (formerly called voltage-gated potassium channel-complex antibodies).
    Bastiaansen AEM; van Sonderen A; Titulaer MJ
    Curr Opin Neurol; 2017 Jun; 30(3):302-309. PubMed ID: 28248701
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distinction between anti-VGKC-complex seropositive patients with and without anti-LGI1/CASPR2 antibodies.
    Yeo T; Chen Z; Yong KP; Wong PYW; Chai JYH; Tan K
    J Neurol Sci; 2018 Aug; 391():64-71. PubMed ID: 30103974
    [TBL] [Abstract][Full Text] [Related]  

  • 3. From VGKC to LGI1 and Caspr2 encephalitis: The evolution of a disease entity over time.
    van Sonderen A; Schreurs MW; Wirtz PW; Sillevis Smitt PA; Titulaer MJ
    Autoimmun Rev; 2016 Oct; 15(10):970-4. PubMed ID: 27485013
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The value of LGI1, Caspr2 and voltage-gated potassium channel antibodies in encephalitis.
    van Sonderen A; Petit-Pedrol M; Dalmau J; Titulaer MJ
    Nat Rev Neurol; 2017 May; 13(5):290-301. PubMed ID: 28418022
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autoimmune encephalitis associated with voltage-gated potassium channels-complex and leucine-rich glioma-inactivated 1 antibodies - a national cohort study.
    Celicanin M; Blaabjerg M; Maersk-Moller C; Beniczky S; Marner L; Thomsen C; Bach FW; Kondziella D; Andersen H; Somnier F; Illes Z; Pinborg LH
    Eur J Neurol; 2017 Aug; 24(8):999-1005. PubMed ID: 28544133
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical spectrum and diagnostic value of antibodies against the potassium channel related protein complex.
    Montojo MT; Petit-Pedrol M; Graus F; Dalmau J
    Neurologia; 2015 Jun; 30(5):295-301. PubMed ID: 24485651
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stop testing for autoantibodies to the VGKC-complex: only request LGI1 and CASPR2.
    Michael S; Waters P; Irani SR
    Pract Neurol; 2020 Oct; 20(5):377-384. PubMed ID: 32595134
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The relevance of VGKC positivity in the absence of LGI1 and Caspr2 antibodies.
    van Sonderen A; Schreurs MW; de Bruijn MA; Boukhrissi S; Nagtzaam MM; Hulsenboom ES; Enting RH; Thijs RD; Wirtz PW; Sillevis Smitt PA; Titulaer MJ
    Neurology; 2016 May; 86(18):1692-9. PubMed ID: 27037230
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intracellular and non-neuronal targets of voltage-gated potassium channel complex antibodies.
    Lang B; Makuch M; Moloney T; Dettmann I; Mindorf S; Probst C; Stoecker W; Buckley C; Newton CR; Leite MI; Maddison P; Komorowski L; Adcock J; Vincent A; Waters P; Irani SR
    J Neurol Neurosurg Psychiatry; 2017 Apr; 88(4):353-361. PubMed ID: 28115470
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LGI1, CASPR2 and related antibodies: a molecular evolution of the phenotypes.
    Binks SNM; Klein CJ; Waters P; Pittock SJ; Irani SR
    J Neurol Neurosurg Psychiatry; 2018 May; 89(5):526-534. PubMed ID: 29055902
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of LGI1 and CASPR2 antibodies with a commercial cell-based assay in patients with very high VGKC-complex antibody levels.
    Yeo T; Chen Z; Chai JYH; Tan K
    J Neurol Sci; 2017 Jul; 378():85-90. PubMed ID: 28566186
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expanding spectrum of contactin-associated protein 2 (CASPR2) autoimmunity-syndrome of parkinsonism and ataxia.
    Kannoth S; Nambiar V; Gopinath S; Anandakuttan A; Mathai A; Rajan PK
    Neurol Sci; 2018 Mar; 39(3):455-460. PubMed ID: 29264691
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insights from LGI1 and CASPR2 potassium channel complex autoantibody subtyping.
    Klein CJ; Lennon VA; Aston PA; McKeon A; O'Toole O; Quek A; Pittock SJ
    JAMA Neurol; 2013 Feb; 70(2):229-34. PubMed ID: 23407760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Emerging psychiatric syndromes associated with antivoltage-gated potassium channel complex antibodies.
    Prüss H; Lennox BR
    J Neurol Neurosurg Psychiatry; 2016 Nov; 87(11):1242-1247. PubMed ID: 27435086
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Chinese female Morvan patient with LGI1 and CASPR2 antibodies: a case report.
    Zhang L; Lu Q; Guan HZ; Mei JH; Ren HT; Liu MS; Peng B; Cui LY
    BMC Neurol; 2016 Mar; 16():37. PubMed ID: 26983964
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of Leucine-Rich Glioma Inactivated Protein 1, Contactin-Associated Protein 2, and Contactin 2 Antibodies With Clinical Features and Patient-Reported Pain in Acquired Neuromyotonia.
    Vincent A; Pettingill P; Pettingill R; Lang B; Birch R; Waters P; Irani SR; Buckley C; Watanabe O; Arimura K; Kiernan MC
    JAMA Neurol; 2018 Dec; 75(12):1519-1527. PubMed ID: 30242309
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Current Perspective on Voltage-gated Potassium Channel Complex Antibody Associated Diseases].
    Watanabe O
    Brain Nerve; 2018 Apr; 70(4):315-328. PubMed ID: 29632280
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Delayed LGI1 seropositivity in voltage-gated potassium channel (VGKC)-complex antibody limbic encephalitis.
    Sweeney M; Galli J; McNally S; Tebo A; Haven T; Thulin P; Clardy SL
    BMJ Case Rep; 2017 Apr; 2017():. PubMed ID: 28432047
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcome of limbic encephalitis with VGKC-complex antibodies: relation to antigenic specificity.
    Malter MP; Frisch C; Schoene-Bake JC; Helmstaedter C; Wandinger KP; Stoecker W; Urbach H; Surges R; Elger CE; Vincent AV; Bien CG
    J Neurol; 2014 Sep; 261(9):1695-705. PubMed ID: 24935858
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical features and outcomes of leucine-rich glioma-inactivated protein 1 and contactin protein-like 2 antibody-associated autoimmune encephalitis in a Chinese cohort.
    Li HY; Qiao S; Cui CS; Feng F; Liu XW; Yang XD
    J Clin Neurosci; 2022 Jul; 101():137-143. PubMed ID: 35597061
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 44.